Nomura Holdings
EW icon

Nomura Holdings’s Edwards Lifesciences EW Stock Holding History

Nomura Holdings’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.77M Buy
+63,800
New +$5.34M 0.01% 740
2026
Q1 		– Sell
-100,000
Closed -$8.53M – 1827
2025
Q4 		$8.53M Sell
100,000
-50,000
-33% -$4.1M 0.01% 590
2025
Q3 		$11.7M Buy
+150,000
New +$11.7M 0.02% 479
2025
Q2 		– Sell
-37,900
Closed -$2.75M – 1617
2025
Q1 		$2.75M Sell
37,900
-55,300
-59% -$3.96M 0.01% 932
2024
Q4 		$6.9M Buy
+93,200
New +$6.52M 0.01% 652
2022
Q4 		– Sell
-17,000
Closed -$1.41M – 1560
2022
Q3 		$1.41M Buy
+17,000
New +$1.64M 0.01% 874

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Nomura Holdings's EW Position: Q2 2026 in Review

Nomura Holdings increased its Edwards Lifesciences (EW) stake by 949% in Q2 2026, buying an estimated $2.45M and bringing the position to 32,343 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Nomura Holdings first reported a position in EW in Q2 2013 and has held it in 36 quarters since. The position peaked at $29.2M in Q1 2024. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Nomura Holdings held 32,343 shares of Edwards Lifesciences worth $2.93M as of Q2 2026.
  • Nomura Holdings bought 29,261 Edwards Lifesciences shares in Q2 2026, an estimated $2.45M.
  • Edwards Lifesciences made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #967 holding.
  • Nomura Holdings first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 36 quarters since.
  • Nomura Holdings's Edwards Lifesciences position peaked at $29.2M in Q1 2024.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.